Phenytoin neurotoxicity in a child carrying new STXBP1 and CYP2C9 gene mutations

• A new mutation in STXBP1 gene in a patient with a clinical history of Ohtahara syndrome and a severe adverse reaction to phenytoin, co-occurring with compound heterozygous mutations in CYP2C9 gene.